share_log
Reuters ·  Apr 30 08:30
NRX Pharmaceuticals Inc - NRX-101 Is First Oral Antidepressant to Show 33% Advantage in Sustained Remission in Suicidality
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment